Your Next Breakthrough Starts Here

Unlock the Power of Bioinformatics, Start Your Demo Today

Experience our Integrated Bioinformatics Platform, designed to accelerate your findings. This solution combines advanced algorithms with intuitive visualizations to boost confidence in results and empower researchers to pioneer discoveries faster than ever.

By entering your email, you agree to receive a follow-up to help you complete your demo

Why Demo our Platform?

  • NPowered by Our Unrivaled Annotated Metabolite Library
  • NIdentify New Contextual Insights With Biomarker Lenses®
  • NSeamless Multiomics Integration
  • NDedicated Microbiome Tools
  • NDesigned for Investigators and Biochemists
  • NTrusted by Leading Scientists
  • NMulti-User, Multi-Site Collaboration
mayo clinic
mayo clinic
mayo clinic
mayo clinic
mayo clinic
mayo clinic

What’s Inside Metabolon’s Integrated Bioinformatics Platform?

Metabolon’s state-of-the-art technology, supported by the most extensive library and meticulously curated pathways, is now bolstered with a new Integrated Bioinformatics Platform, enhancing actionable insight. Incorporating this Bioinformatics Platform with Metabolon’s unrivaled coverage and capability creates an unparalleled solution for metabolomics research worldwide.

This intuitive tool allows you to easily investigate and visualize data to answer basic research questions and can serve as a starting point for your research. Quickly identify metabolite-driven sample groups and overlay sample meta data to uncover relationships to phenotypes.

PLS-DA excels at performing simultaneous dimensionality reduction and classification, allowing researchers to discern patterns associated with different experimental conditions or sample classes. This method is particularly beneficial for identifying biomarkers, distinguishing between physiological states, and predicting class membership for new samples based on their metabolite profiles.

The Volcano plot tool is a powerful visualization tool that combines statistical significance with the magnitude of change in metabolite levels to highlight the most biologically relevant metabolites in your study.

Hierarchical clustering can identify natural groupings within metabolomic datasets by organizing samples or metabolites based on similarity, revealing underlying patterns or distinct biological phenotypes. By visualizing these clusters in dendrograms, you can intuitively interpret metabolic relationships and pinpoint specific biomarkers or metabolic pathways of interest.

Pathway analysis is a powerful tool in bioinformatics and systems biology. It involves the interpretation of various biological pathways to understand the complex interplay of genes, proteins, metabolites, and other molecular entities. By analyzing these pathways, researchers can uncover how different biological processes operate and interact, leading to new insights into disease mechanisms, therapeutic targets, and more.

Biomarker Lenses® in Metabolon’s Bioinformatics Platform are tools that enhance the exploration of metabolomic data by parsing the data into more digestible pieces. Biomarker Lenses™ accomplishes this by grouping the metabolites associated with specific biological functions, pathways, or diseases, thus allowing users to focus on the most relevant areas of biology in the context of their study.

Statistics included within Metabolon’s Integrated Bioinformatics Platform provide additional utility and control for exploring and interpreting your data. As your research grows, the statistics tool supports further hypothesis testing and analyses using key features such as outlier removal and modifying metadata and enables researchers to run additional statistical tests such as T-tests and ANOVAs, all following an easy, step-by-step process.

This tool allows researchers to upload, process, and analyze multiomics data and when combined with Metabolomics data offers the most complete understanding of the phenotype available.

With multiomic predictive modelling, latent factor analysis, and pathway enrichment using REACTOME, the Multiomics Tool enables users to efficiently explore relationships across different omics layers, identify key biomarkers, and rank pathway-level signals within their datasets.

The Microbiome Analysis Tool unifies metagenomic, metabolomic, and phenotypic data within a codeless, accessible platform that simplifies complex analyses without compromising flexibility or analytical depth and rigor. From raw sequencing data to rich visualizations, the platform performs end-to-end processing without requiring manual intervention or custom engineering.

1

Sign Up Online

We need basic details to create your account and then you will get free, immediate access. No payment methods or existing projects/client status needed.

2

Explore our Tools

Experience full access to our demo environment, including supporting documentation and training videos to show you how to make the most of your data.

3

Start a Project

We will connect you with an account manager who can answer any questions about the Integrated Bioinformatics Platform and discuss upcoming projects.

Download the Integrated Bioinformatics Platform eBrochure

Learn more about the tools and capabilities of our Integrated Bioinformatics Platform, a key component of our unparalleled metabolomics service to uncover actionable insights.

GET STARTED

Start your Demo

We need basic details to create your account and then you will get free, immediate access. No payment methods or existing projects/client status needed.

Alternatively, you can request a quote or submit your study here.

Create Your Demo Account

References

1. Zgoda-Pols, J.R., et al., Metabolomics analysis reveals elevation of 3-indoxyl sulfate in plasma and brain during chemically-induced acute kidney injury in mice: investigation of nicotinic acid receptor agonists. Toxicol Appl Pharmacol, 2011. 255(1): p. 48-56.

2. Bryant, J.A., et al., The impact of an oral purified microbiome therapeutic on the gastrointestinal microbiome. Nat Med, 2026. 32(1): p. 186-196

3. McGovern, B .H., et al., SER-109, an Investigational Microbiome Drugto Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial. Clin Infect Dis, 2021. 72(12): p. 2132-2140.

4. Feuerstadt, P., et al., SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection. N Engl J Med, 2022. 386(3): p. 220-229.

5. Hu, Z., et al., Targeted metabolomics reveals novel diagnostic biomarkers for colorectal cancer. Mol Oncol, 2025. 19(6): p. 1737-1750.

6. Butler, F.M., et al., Vegetarian Dietary Patterns and Diet-Related Metabolites Are Associated With Kidney Function in the Adventist Health Study-2 Cohort. J Ren Nutr, 2025.

7. Stanford, J., et al., Metabolomic Profiling and Diet Quality Scoring in a Randomized Crossover Trial of Healthy and Typical Dietary Patterns. Mol Nutr Food Res, 2025 . 69(23): p. e70271.

8. O’Connor, L.E., et al., Metabolomic Profiling of an Ultraprocessed Dietary Pattern in a Domiciled Randomized Controlled Crossover Feeding Trial. J Nutr, 2023. 153(8): p. 2181-2192.

9. Fritsch, D.A., et al., Microbiome function underpins the efficacy of a fiber-supplemented dietary intervention in dogs with chronic large bowel diarrhea. BMC Vet Res, 2022. 18(1): p. 245.

10. Leal, L.N., et al., Preweaning nutrient supply improves lactation productivity and reduces the risk of culling in Holstein cows. J Dairy Sci, 2025. 108(6): p. 5875-5888.

11. Ahsin, M., et al., Soil and pasture health underlie improved beef nutrient density determined by untargeted metabolomics in Southern US grass finished beef systems. NPJ Sci Food, 2025. 9(1): p. 151.

12. Yin, W., et al., Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia. J Lipid Res, 2012. 53(1): p. 51-65.

13. Porter, F .D., et al., Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci Transl Med, 2010. 2(56): p. 56ra81.

14. Needham, B .D., et al., Plasma and Fecal Metabolite Profiles in Autism Spectrum Disorder. Biol Psychiatry, 2021. 89(5): p. 451-462

15. Li, C., et al., Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells. J Exp Med, 2014. 211(1): p. 15-28.

16. Green, P.G., et al., Metabolic flexibility and reverse remodelling of the failing human heart. Eur Heart J, 2025. 46(25): p. 2422-2433.

17. Maekawa, H., et al., SGLT2 inhibition protects kidney function by SAM-dependent epigenetic repression of inflammatory genes under metabolic stress. J Clin Invest, 2025. 135(19).

18. Wu, D., et al., Integrated screens reveal that guanine nucleotide depletion, which is irreversible via targeting IMPDH2, inhibits pancreatic cancer and potentiates KRAS inhibition. Gut, 2026.

19. Schwerdtfeger, L.A., et al., Gut microbiota and metabolites are linked to disease progression in multiple sclerosis. Cell Rep Med, 2025. 6(4): p. 102055.

20. Wu, H., et al., Microbiome-metabolome dynamics associated with impaired glucose control and responses to lifestyle changes. Nat Med, 2025. 31(7): p. 2222-2231.

21. Jacobs, J.P., et al., Cognitive behavioral therapy for irritable bowel syndrome induces bidirectional alterations in the brain-gut-microbiome axis associated with gastrointestinal symptom improvement. Microbiome, 2021. 9(1): p. 236.

22. Pietzner, M., et al., Plasma metabolites to profile pathways in noncommunicable disease multimorbidity. Nat Med, 2021. 27(3): p. 471-479.

23. Faquih, T.O., et al., Robust Metabolomic Age Prediction Based on a Wide Selection of Metabolites. J Gerontol A Biol Sci Med Sci, 2025. 80(3).

24. Scherer, N., et al., Coupling metabolomics and exome sequencing reveals graded effects of rare damaging heterozygous variants on gene function and human traits. Nat Genet, 2025. 57(1): p. 193-205.

25. Holmes, Z.C., et al., Untargeted metabolomic analysis of human milk from healthy mothers reveals drivers of metabolite variability. Sci Rep, 2024. 14(1): p. 20827.

26. Titz, B., et al., Implications of Ocular Confounding Factors for Aqueous Humor Proteomic and Metabolomic Analyses in Retinal Diseases. Transl Vis Sci Technol, 2024. 13(6): p. 17.

27. Bloom, S.M., et al., Cysteine dependence of Lactobacillus iners is a potential therapeutic target for vaginal microbiota modulation. Nat Microbiol, 2022. 7(3): p. 434-450.

28. Leimer, E.M., et al., Lipid profile of human synovial fluid following intra-articular ankle fracture. J Orthop Res, 2017. 35(3): p. 657-666.